Insight Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-401
Closed -$233K 283
2025
Q4
$233K Buy
+401
New +$227K 0.04% 254
2025
Q2
Sell
-454
Closed -$226K 308
2025
Q1
$226K Sell
454
-116
-20% -$62.8K 0.04% 257
2024
Q4
$296K Sell
570
-75
-12% -$41.2K 0.05% 222
2024
Q3
$400K Sell
645
-32
-5% -$18.9K 0.07% 192
2024
Q2
$375K Sell
677
-87
-11% -$49.8K 0.07% 199
2024
Q1
$445K Buy
764
+59
+8% +$33.1K 0.09% 176
2023
Q4
$374K Sell
705
-272
-28% -$132K 0.08% 185
2023
Q3
$495K Sell
977
-123
-11% -$65.5K 0.11% 138
2023
Q2
$574K Buy
1,100
+88
+9% +$47.5K 0.13% 122
2023
Q1
$583K Sell
1,012
-295
-23% -$166K 0.14% 119
2022
Q4
$722K Sell
1,307
-33
-2% -$17.5K 0.25% 101
2022
Q3
$680K Sell
1,340
-1
-0.1% -$560 0.27% 102
2022
Q2
$782K Sell
1,341
-61
-4% -$33.6K 0.27% 99
2022
Q1
$828K Sell
1,402
-101
-7% -$58K 0.25% 112
2021
Q4
$1M Sell
1,503
-192
-11% -$120K 0.3% 86
2021
Q3
$1.08M Sell
1,695
-131
-7% -$71.9K 0.32% 82
2021
Q2
$974K Sell
1,826
-175
-9% -$82.6K 0.31% 85
2021
Q1
$941K Buy
2,001
+316
+19% +$151K 0.3% 92
2020
Q4
$785K Buy
+1,685
New +$790K 0.3% 93

Other funds holding TMO

Insight Advisors's TMO Position: Q1 2026 in Review

Insight Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 401 shares — an estimated $233K sold.

Insight Advisors first reported a position in TMO in Q4 2020 and held it in 19 quarters. The position peaked at $1.08M in Q3 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Insight Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Insight Advisors sold 401 Thermo Fisher Scientific shares in Q1 2026, an estimated $233K.
  • Insight Advisors first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 19 quarters.
  • Insight Advisors's Thermo Fisher Scientific position peaked at $1.08M in Q3 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Insight Advisors's 13F filing for Q1 2026, filed 12 May 2026.